Showing results (61-70 of 79) with videos related to
Sort By:
Pageof 8
Journal of Hepatology|January 1, 1986
The spectrum of liver disease in the acquired immunodeficiency syndromeS C Gordon, K R Reddy, E E Gould, et al.Journal of Viral Hepatitis|November 27, 2010
Hepatitis C treatment among racial and ethnic groups in the IDEAL trialA J Muir, K-Q Hu, S C Gordon, et al.Journal of Viral Hepatitis|November 13, 2001
Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapyJ G McHutchison, J A Shad, S C Gordon, et al.Alimentary Pharmacology & Therapeutics|January 28, 2014
The impact of hepatitis C burden: an evidence-based approachZ M Younossi, F Kanwal, S Saab, et al.Journal of Viral Hepatitis|August 19, 2014
APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS)E Teshale, M Lu, L B Rupp, et al.Lancet (London, England)|October 5, 2001
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialM P Manns, J G McHutchison, S C Gordon, et al.The New England Journal of Medicine|November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy GroupG L Davis, R Esteban-Mur, V Rustgi, et al.The Journal of Social Psychology|September 12, 2000
A multicultural study of stereotyping in English-speaking countriesF T McAndrew, A Akande, R Bridgstock, et al.Journal of Gastrointestinal Cancer|May 25, 2019
Hepatocellular Carcinoma Surveillance in a Cohort of Chronic Hepatitis C Virus-Infected Patients with CirrhosisWinston E Abara, P Spradling, Y Zhong, et al.The New England Journal of Medicine|November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy GroupJ G McHutchison, S C Gordon, E R Schiff, et al.Pageof 8